Search

Author/Creator Rasco, D

1. 390 COM701 (a novel immune checkpoint inhibitor) in patients with advanced solid tumors. (18th September 2019)

Authors:
Elnaggar, A; Luke, J; Hamilton, E; Chmielowski, B; Ileana-Dumbrava, E; Patnaik, A; Lim, E; Adewoye, A; Hunter, J; Olweny, J; Sharma, M; Sullivan, R; Vaena, D; Rasco, D
Journal:
International journal of gynecological cancer
Issue:
Volume 29(2019)Supplement 3
Page Start:
A161
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors. (23rd October 2018)

Authors:
Cho, B C; Perets, R; Bar, J; Ahn, M-J; Kim, D-W; Yoh, K; Nagrial, A; Spigel, D R; Lee, D H; Gutierrez, M; Kotasek, D; Siddiqi, S; Chain, A; Butts, B D; Zhang, Y; Li, X; Cyrus, J; Tse, A; Altura, R A; Rasco, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 422PFirst-in-human study of the monopolar spindle 1 (Mps1) kinase inhibitor BAY 1161909 in combination with paclitaxel in subjects with advanced malignancies. (23rd October 2018)

Authors:
Lorusso, P; Chawla, S P; Bendell, J; Shields, A F; Shapiro, G; Rajagopalan, P; Cyris, C; Bruns, I; Mei, J; Souza, F; Rasco, D; Eder, J P; Tolcher, A W
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 438PSafety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891. (23rd October 2018)

Authors:
Powderly, J; Cassier, P A; Cervantes, A; Gao, B; Gazzah, A; Italiano, A; Lin, C-C; Luke, J J; Moreno, V; Peltola, K; Rasco, D; Spira, A I; Tanner, M M E; Tosi, D; Afar, D; Englert, S; Parikh, A; Reddy, A; Vosganian, G; Tolcher, A W
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 98P Results from a phase I study of MK-1308 (anti–CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancer. (15th December 2019)

Authors:
Cho, B C; Yoh, K; Bar, J; Nagrial, A; Spigel, D R; Gutierrez, M; Kim, D-W; Kotasek, D; Rasco, D; Niu, J; Satouchi, M; Ahn, M-J; Lee, D H; Maurice-Dror, C; Siddiqi, S; Li, X; Cyrus, J; Altura, R A; Perets, R
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗